7Baggers
 Keros Therapeutics: A Potential Dart Throw (NASDAQ:KROS)  Seeking Alpha Thu, 25 Sep 2025 14:15:49 GMT
 published on: 2025-09-18 18:21:20  khodrobank.com Thu, 18 Sep 2025 14:51:53 GMT
 aug fed impact: can keros therapeutics inc. reach all time highs this year  خودرو بانک Mon, 15 Sep 2025 18:31:57 GMT
 keros therapeutics, inc. $kros shares purchased by invesco ltd.  MarketBeat Thu, 11 Sep 2025 07:00:00 GMT
 published on: 2025-09-08 19:14:17  beatles.ru Mon, 08 Sep 2025 16:15:22 GMT
 invesco ltd. has $339,000 stake in keros therapeutics, inc. $kros  MarketBeat Mon, 08 Sep 2025 07:38:49 GMT
 Keros Therapeutics reports positive data for DMD drug candidate  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 Keros Therapeutics Presents Promising Phase 1 Trial Data  TipRanks Mon, 08 Sep 2025 07:00:00 GMT
 published on: 2025-09-03 23:43:48  Newser Thu, 04 Sep 2025 04:43:48 GMT
 published on: 2025-09-03 02:58:10  Newser Wed, 03 Sep 2025 07:58:10 GMT
 published on: 2025-09-01 15:43:13  Newser Mon, 01 Sep 2025 20:43:13 GMT
 published on: 2025-09-01 13:33:23  Newser Mon, 01 Sep 2025 18:33:23 GMT
 published on: 2025-08-31 20:46:26  Newser Mon, 01 Sep 2025 01:46:26 GMT
 published on: 2025-08-31 15:07:16  Newser Sun, 31 Aug 2025 20:07:16 GMT
 published on: 2025-08-31 12:42:07  Newser Sun, 31 Aug 2025 17:42:07 GMT
 published on: 2025-08-30 17:09:51  Newser Sat, 30 Aug 2025 22:09:51 GMT

Keros Therapeutics, Inc
(NASDAQ:KROS) 

KROS stock logo

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, wh...

Founded: 2015
Full Time Employees: 32
CEO: Jasbir S. Seehra  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends